The era of precision medicine is now.
TSH provide various convenient, time-saving, and accurate detection.
Risk of genetic disease
Lifetime risk assessment
- Comprehensively screen 98 inherited cancer related genes.
- Clinical evidence based variant interpretation.
- High cost effectiveness
Current risk assessment
- Minimally invasive.
- Development based on large clinical study in Taiwan, first in the world.
- Fast and accurately evaluate endometrial cancer risk.
Surgery or treatment follow-up
- Non-invasive liquid biopsy (ctDNA or CTC).
- Real-time monitoring.
- Two NGS sequencing (plasma cfDNA and WBC gDNA)
- CTC test based on large CRC clinical study in Taiwan.
- MRD follow-up.
Comprehensive targeted therapies survey
- Low false negativity and positivity ctDNA liquid biopsy.
- Actionable drug related genes panel.
- Flexible testing choices (tissue or liquid).